Privacy Policy
Signals Blog

Contributors

Categories

.

Sometimes too much choice can be a bad thing. It paralyzes you.

I was flummoxed by the many options available to me in selecting what to feature on Right Turn this week. Then it struck me: I have the perfect item right under my nose (so to speak).

CCRM just launched a Regenerative Medicine Video Network. Working with groups like Let’s Talk Science, the Stem Cell Network, InfoShots and others (new videos will be added regularly), the site will feature original content (a regenerative medicine leadership series, lab protocols, public outreach videos, etc.) and previously posted content that merits a second showing.

Forgive me for using Right Turn as a place to promote CCRM initiatives, but this interview with Dr. Stephen Minger, of GE Healthcare Life Sciences, is exactly what I would choose to feature if I stumbled upon it online.  Watch for yourself and see if you don’t agree.

 

 

Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.

As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.

The following two tabs change content below.
Avatar photo

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.